Literature DB >> 15527464

Review article: oesophageal complications and consequences of persistent gastro-oesophageal reflux disease.

J Pisegna1, G Holtmann, C W Howden, P H Katelaris, P Sharma, S Spechler, G Triadafilopoulos, G Tytgat.   

Abstract

The major oesophageal complications associated with persistent gastro-oesophageal reflux disease (GERD) include erosive oesophagitis, ulceration, strictures and gastrointestinal (GI) bleeding. Although the causes of these complications are uncertain, studies indicate that erosive oesophagitis may progress to the development of ulcers, strictures and GI bleeding. Pharmacological treatment with proton pump inhibitors is favoured over that with H(2)-receptor antagonists for the treatment of strictures. The treatment of strictures is accomplished with dilation and many favour the concomitant use of proton pump inhibitors. Most gastroenterologists are seeing far fewer oesophageal strictures these days since the introduction of proton pump inhibitors. In addition, research has shown that oesophageal complications have a greater impact on patients suffering from night-time GERD than on those suffering from daytime GERD. Barrett's oesophagus is a significant complication associated with persistent GERD and those at risk generally experience a longer duration of symptoms, especially those with a high degree of severity. In addition, there is a strong relationship between Barrett's oesophagus and oesophageal adenocarcinoma. This is in part due to the association of obesity and the development of hiatal hernias. Furthermore, endoscopic screening is being used to detect Barrett's oesophagus and oesophageal adenocarcinoma in persons suffering from chronic GERD, even though screening may not have an impact on outcomes (Sharma P, McQuaid K, Dent J, et al. A critical review of the diagnosis and management of Barrett's esophagus: The AGA Chicago Workshop. Gastroenterology 2004; 127: 310-30.).

Entities:  

Mesh:

Year:  2004        PMID: 15527464      PMCID: PMC6736593          DOI: 10.1111/j.1365-2036.2004.02240.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  77 in total

Review 1.  Unresolved issues in Barrett's esophagus in the new millennium.

Authors:  G Falk
Journal:  Dig Dis       Date:  2000       Impact factor: 2.404

2.  Overweight, but not high dietary fat intake, increases risk of gastroesophageal reflux disease hospitalization: the NHANES I Epidemiologic Followup Study. First National Health and Nutrition Examination Survey.

Authors:  C E Ruhl; J E Everhart
Journal:  Ann Epidemiol       Date:  1999-10       Impact factor: 3.797

3.  Helicobacter pylori and the efficacy of omeprazole therapy for gastroesophageal reflux disease.

Authors:  B E Schenk; E J Kuipers; E C Klinkenberg-Knol; S A Eskes; S G Meuwissen
Journal:  Am J Gastroenterol       Date:  1999-04       Impact factor: 10.864

4.  Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole.

Authors:  G Holtmann; C Cain; P Malfertheiner
Journal:  Gastroenterology       Date:  1999-07       Impact factor: 22.682

5.  Helicobacter pylori and Gastric Cancer.

Authors: 
Journal:  Oncologist       Date:  1998

6.  The influence of Helicobacter pylori on oesophageal acid exposure in GERD during acid suppressive therapy.

Authors:  F T Peters; E J Kuipers; S Ganesh; W J Sluiter; E C Klinkenberg-Knol; C B Lamers; J H Kleibeuker
Journal:  Aliment Pharmacol Ther       Date:  1999-07       Impact factor: 8.171

7.  The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry.

Authors:  J B O'Connor; G W Falk; J E Richter
Journal:  Am J Gastroenterol       Date:  1999-08       Impact factor: 10.864

8.  Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma.

Authors:  J Lagergren; R Bergström; A Lindgren; O Nyrén
Journal:  N Engl J Med       Date:  1999-03-18       Impact factor: 91.245

9.  Association of obesity with hiatal hernia and esophagitis.

Authors:  L J Wilson; W Ma; B I Hirschowitz
Journal:  Am J Gastroenterol       Date:  1999-10       Impact factor: 10.864

10.  Helicobacter pylori infection inhibits reflux esophagitis by inducing atrophic gastritis.

Authors:  T Koike; S Ohara; H Sekine; K Iijima; K Kato; T Shimosegawa; T Toyota
Journal:  Am J Gastroenterol       Date:  1999-12       Impact factor: 10.864

View more
  10 in total

1.  Comparative efficacy of rabeprazole and pantoprazole in the control of nocturnal Acid output and intragastric acidity.

Authors:  Hank S Wang; David S Oh; Ariana Anderson; Jose Nieto; Phuong Tien; Gordon Ohning; Joseph R Pisegna
Journal:  Gut Liver       Date:  2008-06-30       Impact factor: 4.519

Review 2.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

3.  Association between body mass index and erosive esophagitis: a meta-analysis.

Authors:  Nan Cai; Guo-Zhong Ji; Zhi-Ning Fan; Yan-Feng Wu; Fa-Ming Zhang; Zhi-Fei Zhao; Wei Xu; Zheng Liu
Journal:  World J Gastroenterol       Date:  2012-05-28       Impact factor: 5.742

4.  Risk of hemorrhage and stricture significantly increases in elderly patients with proton pump inhibitor (PPI)-resistant reflux esophagitis.

Authors:  Nana Takenouchi; Shintaro Hoshino; Yoshimasa Hoshikawa; Tomohide Tanabe; Mai Koeda; Eri Momma; Yumiko Ishikawa; Noriyuki Kawami; Mitsuru Kaise; Katsuhiko Iwakiri
Journal:  Esophagus       Date:  2019-11-02       Impact factor: 4.230

5.  Esophageal Adenocarcinoma Developing after Eradication of Helicobacter pylori.

Authors:  Yasuhiko Abe; Tomoyuki Koike; Katsunori Iijima; Akira Imatani; Kazuhiko Ishida; Toyohiko Yuki; Go Miyata; Tooru Shimosegawa
Journal:  Case Rep Gastroenterol       Date:  2011-07-08

6.  Gastroesophageal reflux disease and tooth erosion.

Authors:  Sarbin Ranjitkar; John A Kaidonis; Roger J Smales
Journal:  Int J Dent       Date:  2011-12-12

7.  Lifestyle factors affecting gastroesophageal reflux disease symptoms: a cross-sectional study of healthy 19864 adults using FSSG scores.

Authors:  Nobutake Yamamichi; Satoshi Mochizuki; Itsuko Asada-Hirayama; Rie Mikami-Matsuda; Takeshi Shimamoto; Maki Konno-Shimizu; Yu Takahashi; Chihiro Takeuchi; Keiko Niimi; Satoshi Ono; Shinya Kodashima; Chihiro Minatsuki; Mitsuhiro Fujishiro; Toru Mitsushima; Kazuhiko Koike
Journal:  BMC Med       Date:  2012-05-03       Impact factor: 8.775

8.  Factors associated with complicated erosive esophagitis: A Japanese multicenter, prospective, cross-sectional study.

Authors:  Masahiro Sakaguchi; Noriaki Manabe; Nobuo Ueki; Jun Miwa; Tomoki Inaba; Norimasa Yoshida; Kouichi Sakurai; Masahiro Nakagawa; Hajime Yamada; Michiya Saito; Koji Nakada; Katsuhiko Iwakiri; Takashi Joh; Ken Haruma
Journal:  World J Gastroenterol       Date:  2017-01-14       Impact factor: 5.742

9.  Gastric Hypersecretory States: Investigation and Management.

Authors:  Jennifer Phan; Jihane N Benhammou; Joseph R Pisegna
Journal:  Curr Treat Options Gastroenterol       Date:  2015-12

10.  Effects of Life style factors on the symptoms of gastro esophageal reflux disease: A cross sectional study in a Pakistani population.

Authors:  Shahid Ahmed; Sajjad Jamil; Hafeezullah Shaikh; Maryam Abbasi
Journal:  Pak J Med Sci       Date:  2020 Jan-Feb       Impact factor: 1.088

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.